AB-3PRGD2 is a radiolabeled agent that targets integrin alphavbeta3. It enhances tumor uptake and prolongs retention time in tumors, significantly improving the inhibition of tumor growth. AB-3PRGD2 also remodels the tumor immune microenvironment by upregulating PD-L1 expression and increasing tumor-infiltrating CD8+ T cells.
Molekulargewicht:
3161.32
CAS Nummer:
[2416165-76-7]
Formel:
C137H215IN30O45S
Target-Kategorie:
Integrin,PD-1/PD-L1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
